Sign in
4

Changes in Ownership

LENZ Therapeutics, Inc. Filed Acc 0000950170-25-111529

10% owner sold 188,094 shares at an average $39.47 ($7,423,920)

From the SEC's structured data for this filing

Trades in this filing

Versant Venture Capital VI, L.P. · 10% owner

Table I: Non-derivative

12 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-22 Sale : show line 1 in the form −20,493 $40.03 $820,329 1,379,727 D
2025-08-22 Sale : show line 2 in the form −10,076 $40.03 $403,339 952,802 I
2025-08-22 Sale : show line 3 in the form −5,668 $40.59 $230,064 1,374,059 D
2025-08-22 Sale : show line 4 in the form −2,809 $40.59 $114,017 949,993 I
2025-08-25 Sale : show line 5 in the form −50,270 $39.53 $1,986,947 1,323,789 D
2025-08-25 Sale : show line 6 in the form −24,760 $39.53 $978,651 925,233 I
2025-08-25 Sale : show line 7 in the form −2,149 $39.92 $85,791 1,321,640 D
2025-08-25 Sale : show line 8 in the form −1,058 $39.92 $42,237 924,175 I
Open-market sales · 188,094 sh · avg $39.47 · $7,423,920
Loading xslF345X05/ownership.xml…